Endothelins and their receptors as biological markers for oral cancer

Oral Oncology

Volumn 46, Issue 9, 2010, Pages 644-647

  Hoffmann, Renata R ^a   Yurgel, Liliane S ^a   Campos, Maria M ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Endothelin receptors; Endothelin 1; Oral cancer; Prognostic factor

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; TUMOR MARKER;

CANCER CELL CULTURE; CANCER GROWTH; HUMAN; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; ENDOTHELINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOUTH NEOPLASMS; PROGNOSIS; RECEPTORS, ENDOTHELIN; TUMOR MARKERS, BIOLOGICAL;

EID: 77956392148     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.06.015     Document Type: Review

References (54)

1. S.C. Girod, P. Pfeiffer, J. Ries, and H.-D. Pape Proliferative activity and loss of function of tumour supressor genes as "biomarkers" in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma Br J Oral Maxillofac Surg 36 1998 252 260
2. J.A. Regezi, and R.C. Jordan Oral cancer in the molecular age J Calif Dent Assoc 29 8 2001 578 584
3. C.T. Viet, R.C. Jordan, and B.L. Schmidt DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer J Calif Dent Assoc 35 12 2007 844 849
4. Z.S. Peacock, M.A. Pogrel, and B.L. Schimidt Exploring the reasons for delay in treatment of oral cancer J Am Dent Assoc 139 10 2008 1346 1352
5. C.T. Viet, and B.L. Schmidt Understanding oral cancer in the genome era Head Neck 2010 DOI 10.1002/hed
6. K.A. Hickey, G. Rubanyi, R.J. Paul, and R.F. Highsmith Characterization of a coronary vasoconstrictor produced by cultured endothelial cells Am J Phisiol 248 1985 C550 C556
7. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
8. E.R. Levin Endothelins N Eng J Med 333 1995 356 363
9. A.P. Davenport International union of pharmacology. XXIX. Update on endothelin receptor nomenclature Pharmacol Rev 54 2002 219 226
10. H. Kusserow, and T. Unger Vasoacitive peptides, their receptors and drug development Basic Clin Pharmacol Toxicol 94 2004 5 12
11. A. Goraca New views on the role of endothelin Endocr Regul 36 2002 161 167
12. S. Motte, K. Mcentee, and R. Naeije Endothelin receptor antagonists Pharmacol Ther 110 2006 386 414
13. A. Bhalla, S. Haque, I. Taylor, M. Winslet, and M. Loizidou Endothelin receptor antagonism and cancer Eur J Clin Invest 39 S2 2009 74 77
14. T.A. Guise, J.J. Yin, and K.S. Mohammad Role of endothelin-1 in osteoblastic bone metastases Cancer 97 S3 2003 779 784
15. F. Ducancel Endothelin-like peptides Cell Mol Life Sci 62 2005 2828 2839
16. M. Yanagisawa, and T. Masaki Endothelin, a novel endothelium-derived peptide Biochem Pharmacol 38 12 1989 1877 1883
17. M. Gössl, and A. Lerman Endothelin: Beyond a vasoconstrictor Circulation 113 2006 1156 1158
18. K. Langhmani, P.A. Preisig, and R.J. Alpern The role of endothelin in proximal tubule próton secretion and the adaptation to a chronic metabolic acidosis J Nephrol 15 S5 2002 S75 S87
19. T.D. Plant, C. Zöllner, S.A. Mousa, and A. Oksche Endothelin-1 potentiates capsaicin-induced TRPV1 currents via the Endothelin-A recptor Exp Biol Med 231 2006 1161 1164
20. B recptor sntagonist reduces mechanical allodynia in rats with trigeminal neuropathic pain Exp Biol Med 231 2006 1136 1140
21. T. Ansai, E. Yamamoto, S. Awano, Yu. Weixian, A.J. Turner, and T. Takehara Effects of periodontopathic bacteria on the expression of endothelin-1 in gingival epithelial cells in adults periodontitis Clin Sci 103 S48 2002 327s 331s
22. E. Yamamoto, S. Awano, T. Koseki, T. Ansai, and T. Takehara Expression of endothelin-1 in gingival epithelial cells J Periodont Res 38 2003 417 421
23. A. Bagnato, F. Spinella, and L. Rosan Emerging role of the axis in ovarian tumor progression Endocr Relat Cancer 12 2005 761 772
24. A. Bagnato, F. Spinella, and L. Rosan The endothelin axis in cancer: the promise and the challenges of molecularly target therapy Can J Physiol Pharmacol 86 2008 473 484
25. A. Bagnato, and L. Rosan The endothelin axis in cancer Int J Biochem Cell Biol 40 2008 1443 1451
26. M.J. Grimshaw Endothelins in breast tumor cell invasion Cancer Letter 222 2005 129 138
27. K. Alanen, D.X. Deng, and S. Chakrabarti Augmented expression of endothelin-1, endothelin-2, endothelin-3 and endothelin-B receptor in breast carcinoma Histopathology 36 1999 161 167
28. M. Ishibashi, M. Fujita, K. Nagai, M. Kako, H. Furue, and E. Haku Production and secretion of endotelin by hepatocelular carcinoma J Clin Endocrinol Metab 76 2 1993 378 383
29. H.-C. Lam, G.-H. Lo, J.-K. Lee, C.-C. Lu, C.-H. Chu, and C.-C. Sun Salivary immunoreactive endothelin in patients with upper gastrointestinal diseases J Cardiovasc Pharmacol 44 S1 2004 S413 S417
30. W. Jiao, J. Xu, H. Pan, T.-Y. Wang, and Y. Shen Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B World J Gastroenterol 13 29 2007 4002 4005
31. W. Jiao, J. Xu, J. Zheng, Y. Shen, L. Lin, and J. Li Elevation of circulating big ET-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma BMC Cancer 15 8 2008 334
32. G. Pelosi, M. Volante, M. Papotti, A. Sonzogni, M. Masullo, and G. Viale Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy Q J Nucl Med Mol Imaging 50 2006 272 287
33. 2+ Life Sciences 82 2008 764 771
34. B. Titus, H.F. Frierson Jr, M. Conaway, K. Ching, T. Guise, and J. Chirgwin Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2 Cancer Res 65 16 2005 7320 7327
35. D. Cella, D.P. Petrylak, M. Fishman, C. Teigland, J. Young, and P. Mulani Role of quality of life in men with metastatic hormone-refractory prostate cancer: How does Atrasentan influence quality of life? Eur Urol 49 2006 781 789
36. R. Lahav Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma Int J Dev Biol 49 2005 173 180
37. C-Ce Lan, C.-S. Wu, C.-M. Cheng, C.-L. Yu, G.-S. Chen, and H.-S. Yu Pigmentation in basal cell carcinoma involves enhanced endothelin-1 expression Exper Dermatol 14 2005 528 534
38. Y. Berger, C.C. Bernasconi, and L. Juillerat-Jeanneret Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents Exp Biol Med 231 2006 1111 1119
39. F. Spinella, L. Rosan, G. Elia, V. Di Castro, P.G. Natali, and A. Bagnato Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor J Cardiovasc Pharmacol 44 S1 2004 S140 S143
40. L. Rosan, F. Spinella, V. Di Castro, S. Dedhar, M.R. Nicotra, and P.G. Natali Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma Mol Cancer Ther 5 4 2006 833 842
41. F. Spinella, L. Rosan, V. Di Castro, S. Decandia, A. Albini, and Nicotra. MRet Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma Mol Cancer Ther 5 6 2006 1483 1492
42. F. Spinella, L. Rosan, S. Decandia, V. Di Castro, A. Albini, and G. Elia Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target Exp Biol Med 231 2006 1123 1127
43. L. Rosan, F. Spinella, V. Di Castro, S. Decandia, M.R. Nicotra, and P.G. Natali Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression Exp Biol Med 231 2006 1128 1131
44. S. Awano, L.A. Dawson, A.R. Hunter, A.J. Turner, and B.A. Usmani Endothelin system in oral squamous carcinoma cells: Specific siRNA targeting of ECE-1 blocks cell proliferation Int J Cancer 118 2006 1645 1652
45. V. Pickering, R.C. Jordan, and B.L. Schmidt Elevated salivary endothelin levels in oral cancer patients-a pilot study Oral Oncol 43 1 2007 37 41
46. G. Hans, B.L. Schmidt, and G. Strichartz Nociceptive sensitization by endothelin-1 Brain Res Rev 60 2009 36 42
47. A. Khodorova, J.-P. Montmayer, and G. Strichartz Endothelin receptors and pain J Pain 10 1 2009 4 28
48. V. Pickering, R.J. Gupta, P. Quang, R.C. Jordan, and B.L. Schmidt Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice Eur J Pain 12 3 2008 293 300
49. B.L. Schmidt, V. Pickering, S. Liu, P. Quang, J. Dolan, and S.T. Connelly Peripheral endothelin-A receptor antagonism attenuates carcinoma-induced pain Eur J Pain 11 2007 406 414
50. Quang PN, Schmidt BL. Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice. The J Pain 2010, in press.
51. P.N. Quang, and B.L. Schmidt Peripheral endothelin-B receptor agonist-induced antinociception involves endogenous opioids in mice Pain 149 2 2010 254 262
52. J. Nelson, A. Bagnato, B. Battistini, and P. Nisen The endothelin axis: emerging role in cancer Nat Rev Cancer 3 2 2003 110 116
53. A. Bagnato, and F. Spinella Emerging role of endothelin-1 in tumor angiogenesis TRENDS Endocrinol Metabol 14 1 2002 44 50
54. M.J. Grimshaw Endothelins and hypoxia-inducible factor in cancer Endocr Relat Cancer 14 2007 233 244